Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020
Rzgar Tawfeeq Kareem, Fahimeh Abedinifar, Evan Abdolkareem Mahmood, et al.
RSC Advances (2021) Vol. 11, Iss. 49, pp. 30781-30797
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Correlating the charge transfer efficiency of metallic sulfa-isatins to design efficient NLO materials with better drug designs
Sadaf Noreen, Sajjad Hussain Sumrra
BioMetals (2022) Vol. 35, Iss. 3, pp. 519-548
Closed Access | Times Cited: 57
Structural characterization and biological evaluation of uracil-appended benzylic amines as acetylcholinesterase and carbonic anhydrase I and II inhibitors
Zafer Bulut, Nurgül Abul, Ayşe Halıç Poslu, et al.
Journal of Molecular Structure (2023) Vol. 1280, pp. 135047-135047
Closed Access | Times Cited: 21
Colorimetric Assay for Acetylcholinesterase Activity and Inhibitor Screening Based on Metal–Organic Framework Nanosheets
Yu Wang, Yu Xue, Qilin Zhao, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 47, pp. 16345-16352
Closed Access | Times Cited: 29
In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer’s Diseases
Kassim F. Adebambo, Oghenekevwe Ojoh
International Journal of Alzheimer s Disease (2024) Vol. 2024, pp. 1-19
Open Access | Times Cited: 5
Spectroscopic Characterization Using 1H and 13C Nuclear Magnetic Resonance and Computational Analysis of the Complex of Donepezil with 2,6-Methyl-β-Cyclodextrin and Hydroxy Propyl Methyl Cellulose
Nikoletta Zoupanou, Paraskevi Papakyriakopoulou, Nikitas Georgiou, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1169-1169
Open Access
Development of novel 9H-carbazole-4H-chromene hybrids as dual cholinesterase inhibitors for the treatment of Alzheimer’s disease
Nissi Sharon, Vinod G. Ugale, Pannala Padmaja, et al.
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 379-396
Closed Access | Times Cited: 4
Piperidine: A Versatile Heterocyclic Ring for Developing Monoamine Oxidase Inhibitors
Jayalakshmi Jayan, Namitha Chandran, Amrutha Chandran Thekkantavida, et al.
ACS Omega (2023) Vol. 8, Iss. 41, pp. 37731-37751
Open Access | Times Cited: 11
Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer’s Disease Activity
Melford C. Egbujor
Central Nervous System Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 1, pp. 82-104
Closed Access | Times Cited: 3
A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer's disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access | Times Cited: 3
Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 4
Closed Access | Times Cited: 3
New Indole Derivatives As Multitarget anti-Alzheimer's Agents: synthesis, Biological Evaluation and Molecular Dynamics
Eman M. Azmy, Ibrahim F. Nassar, Mohamed Hagras, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 6, pp. 473-495
Closed Access | Times Cited: 9
Design, Synthesis, and Biological Activity of Donepezil: Aromatic Amine Hybrids as Anti-Alzheimerss Drugs
Dan Wan, Fengqin Wang, Jiang Xie, et al.
ACS Omega (2023) Vol. 8, Iss. 24, pp. 21802-21812
Open Access | Times Cited: 9
Voglibose attenuates cognitive impairment, Aβ aggregation, oxidative stress, and neuroinflammation in streptozotocin-induced Alzheimer’s disease rat model
Manickam Rajkumar, Soundarapandian Kannan, Ramasundaram Thangaraj
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2751-2771
Closed Access | Times Cited: 9
Synthesis and study of the biological activity of thiourea-containing amiridine derivatives as potential multi-target drugs for the treatment of Alzheimer’s disease
Галина Ф. Махаева, Alexey N. Proshin, N. V. Kovaleva, et al.
Russian Chemical Bulletin (2022) Vol. 71, Iss. 11, pp. 2404-2415
Closed Access | Times Cited: 15
Proposing novel natural compounds against Alzheimer’s disease targeting acetylcholinesterase
Münteha Girgin, Sevim Işık, Nigar Kantarci-Carsibasi
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284994-e0284994
Open Access | Times Cited: 7
Molecular docking and toxicity studies of nerve agents against acetylcholinesterase (AChE)
Mikael Ham Sembiring, Okta Nursanti, Tesia Aisyah Rahmania
Journal of Receptors and Signal Transduction (2023) Vol. 43, Iss. 5, pp. 115-122
Closed Access | Times Cited: 6
Investigating the multifunctionality of fluorinated donepezil derivatives for Alzheimer’s disease
Sunandini Swain, Anik Sen, Atanu K. Metya
Journal of Molecular Liquids (2024) Vol. 409, pp. 125500-125500
Closed Access | Times Cited: 1
A Series of Novel 1-H-isoindole-1,3(2H)-dione Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: In Silico, Synthesis and In Vitro Studies
Edward Krzyżak, Aleksandra Marciniak, Dominika Szkatuła, et al.
Molecules (2024) Vol. 29, Iss. 15, pp. 3528-3528
Open Access | Times Cited: 1
In Situ Biomineralization and Citric Acid Etching Strategy for Enhancing Activity of Immobilized Acetylcholinesterase
Xing Chang, Xinru Zhang, Yin Qiang, et al.
Langmuir (2024) Vol. 40, Iss. 43, pp. 22794-22802
Closed Access | Times Cited: 1
Investigating the chemical profile of Rheum lhasaense and its main ingredient of piceatannol-3′-O-β-D-glucopyranoside on ameliorating cognitive impairment
Yue Wang, Qing Liu, Qiuyue Lv, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114394-114394
Open Access | Times Cited: 4
Hylocereus undatus extends lifespan and exerts neuroprotection in Caenorhabditis elegans via DAF-16 mediated pathway
Mani Iyer Prasanth, Anchalee Prasansuklab, Kanika Verma, et al.
Nutrition and Healthy Aging (2023) Vol. 8, Iss. 1, pp. 79-95
Open Access | Times Cited: 3
Exploration of the novel phthalimide-hydroxypyridinone derivatives as multifunctional drug candidates against Alzheimer’s disease
Xi Zhu, Yangjing Lv, Miaoliang Fan, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106817-106817
Closed Access | Times Cited: 3
Design, synthesis and evaluation of benzo[cd]indol-2(1H)-one-donepezil hybrids as cholinesterase inhibitors and living cell imaging agents
Junjie Wang, Hui Zhou, Li Yang, et al.
Journal of Molecular Structure (2023) Vol. 1285, pp. 135511-135511
Closed Access | Times Cited: 2
Novel acetylcholinesterase inhibitors: Synthesis, docking and inhibitory activity evaluation of 4-benzamido-N-(1-benzylpiperidin-4-yl) benzamide derivatives
Ahmad Mohammadi-Farani, Sara Nazari, Mahsa Mohammadi, et al.
Results in Chemistry (2023) Vol. 7, pp. 101273-101273
Open Access | Times Cited: 2
5-Aryl-1,3,4-oxadiazol-2-amines Decorated with Long Alkyl and Their Analogues: Synthesis, Acetyl- and Butyrylcholinesterase Inhibition and Docking Study
Václav Pflégr, Šárka Štěpánková, Katarína Svrčková, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 400-400
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top